Research Teams in an Australian Biotechnology Field: How Intellectual Property Influences Collaboration

The purpose of this paper is to examine how research teams serve as building blocks for collaboration at a field level, and how these building blocks are assembled by a network of interacting organizations. The field setting is a medical sciences consortium in Australia established to encourage collaborative and entrepreneurial research among government, industry, research centers and university units. This consortium is examined as a case study. The analysis demonstrates how collaboration evolved at three interacting levels: research team, organization and interorganizational field.

The main findings are: (1) Intellectual property (IP) acts as the key orienting agent in this field to align the behavior of various stakeholders and leverage collaborative and entrepreneurial activity. (2) Tensions between the different ways that the commercial and public sector actors value IP serve to structure the interfaces among the consortium, the member organizations and the research teams. (3) The consortium is a key infrastructural element in the creation of collaborative capital in the Australian biotechnology field studied. The main contribution of the study is to highlight the nature of collaborative capital at a field level and begin to explore its implications.